PATENT CLAIM ANALYSIS

Application Number: 15887671
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["435", "039000"]

Abstract:
A blood test method includes providing a blood sample containing an anticoagulant containing an ethylenediaminetetraacetic acid (EDTA) salt other than a sodium, potassium, or calcium salt of EDTA, and then measuring a blood count and an electrolyte in the provided blood sample.

Claim (Index 2):
The blood test method according to  claim 1 , further comprising measuring at least one item selected from the group consisting of a C-reactive protein (CRP), a serum amyloid protein A (SAA), a tumor necrosis factor (TNF), interleukin-1 (IL-1), \u00aa1-antitrypsin, \u00aa1-antichymotrypsin, \u00aa1-acidic glycoprotein, haptoglobin, ceruloplasmin, troponin I, CK-MB, myoglobin, and a heart-type fatty acid-binding protein (H-FABP) in the blood sample.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.41176
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12339886', '13825047', '10226825', '13565930', '14568549']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5800626621955558
- 35 USC 102 Novelty (BERT): 0.4900201571988324
- Combined Prediction Score: 0.5710584116958836
- Mean Citation Score: 195.951734
- Max Citation Score: 202.87549
- Similarity Product: 135.8629639823592

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test